SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Opto Circuits India set to introduce next generation medical products into world markets

10 Dec 2009 Evaluate

Opto Circuits India Limited (OCI), India's indigenously grown international medical device company, has released its new generation medical technologies for the world markets. 5 critical new offerings, 3 from its Wisconsin - based subsidiary Criticare Systems Inc. and 2 from Bonn - based subsidiary Eurocor GmbH, ready to be introduced to distributors and clinicians around the world.

 

Criticare Systems Inc. (CSI) has brought in its first ever modular and green patient monitoring system - eVision 9100. It has also developed a modular gas bench - Poet© IQ 8500H that provides a unique combination of leading edge vital signs technology and anesthesia gas monitoring in a compact, modular system. Another new addition to the range is eTraq, a compact, portable, multi-parameter monitor.

 

Eurocor has come out with a path-breaking concept in occluding diseased arteries of the heart - Magical, a CE-marked novel drug-clung option that combines a bare metal stent with a drug-coated balloon for rapid healing without long-term anti-platelet therapy. The product is set to compete with conventional drug-eluting stent options for some applications. Yet another invasive drug Freeway, is slated to be a prime   option   for   interventionists   treating   diabetic   and    atherosclerotic.

crackcrack

Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 547.55
Poly Medicure 1453.45
Laxmi Denta 189.60
Nureca Ltd. 258.40
Hemant Surgical Inds 295.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×